SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Brun Eva)
 

Sökning: WFRF:(Brun Eva) > (2015-2019) > Prediction of side ...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00006273nam a2200457 4500
001oai:DiVA.org:liu-162101
003SwePub
008191119s2019 | |||||||||||000 ||eng|
020 a 9789179299569q print
024a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-1621012 URI
024a https://doi.org/10.3384/diss.diva-1621012 DOI
040 a (SwePub)liu
041 a engb eng
042 9 SwePub
072 7a vet2 swepub-contenttype
072 7a dok2 swepub-publicationtype
100a Oliva, Delmy,d 1967-u Linköpings universitet,Avdelningen för Kirurgi, Ortopedi och Onkologi,Medicinska fakulteten4 aut0 (Swepub:liu)delol26
2451 0a Prediction of side effects from anticancer treatment with the purpose of increasing quality of life
264 1a Linköping :b Linköping University Electronic Press,c 2019
300 a 93 s.
338 a electronic2 rdacarrier
490a Linköping University Medical Dissertations,x 0345-0082 ;v 1716
520 a Cancer and its treatments can cause a variety of symptoms. Some of these symptoms are related to the disease and others are seen as a consequence of the treatment. Since patients experience side effects to different degrees despite undergoing the same treatment, it is hypothesized that there is a genetic factor. The individual variation that exists between different patients regarding nausea triggered by chemotherapy, radiotherapy induced skin reactions as well as sleep disorders associated with cancer could partly be explained by genetic differences. We have in these studies confirmed these individual differences. Previous nursing research has mainly focused on the symptoms themselves. The focus in this thesis are the following three main symptoms; nausea and vomiting related to chemotherapy, acute skin inflammation following radiotherapy and sleep problems associated with cancer diagnosis and -treatment.The aim of this thesis was to find biological markers that can identify the risk of and/or protective factors for nausea and/or vomiting (CINV) as well as understand its heterogeneity (Study 1 and 2). It also aimed to understand the individual factors behind acute radiation skin reactions (ARSR) (Study 3) and sleeping disturbances in patients treated for cancer (Study 4), permitting a more individualized care and optimized health-related quality of life (HRQoL).In Study 1 and 2 the patients themselves had to document in a diary their experience of nausea and vomiting and well-being. Well-being was considered as synonymous with quality of life. We found a variability and heterogeneity of those symptoms (Study 1). Three genetic markers, FAS/CD95, RB1/LPAR6 and CCL2 that could explain the individual differences and assess the risk of chemotherapy-induced nausea were found in Study 2.Acute radiation skin reactions (ARSR) along with itching and burning sensation associated with radiotherapy (RT) was assessed by the patients themselves (Study 3) with help of the VAS- and RTOG scales, scoring for visible redness. We found two possible genetic markers, XRCC2 and IFNG. Also, individual differences in symptoms behavior were found.Sleep disturbances were common and were reported with obvious individual differences [1]. For data collection were used a sleep questionnaire, the Medical Outcomes Study Sleep Scale (MOS), open ended questions and EORTC QLQ- C30 questionnaire of quality of life. Sleep, which is important for all primary body functions, is often affected in connection with cancer diagnosis and -treatment.Through collaboration between nursing staff and specialists in basic science, we have found that biological markers can help in creating individualized care. Knowledge of individual variations in the severity of chemo- or radiotherapy-induced side effects is important in order to better personalize the treatment and care, improve the treatment results and alleviate or prevent the side effects of oncological treatments. By linking symptoms to biological markers, it will hopefully be able to increase the patients’ total health-related quality of life, this being the main goal of this thesis.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng
650 7a MEDICIN OCH HÄLSOVETENSKAPx Hälsovetenskapx Omvårdnad0 (SwePub)303052 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Health Sciencesx Nursing0 (SwePub)303052 hsv//eng
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Radiologi och bildbehandling0 (SwePub)302082 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Radiology, Nuclear Medicine and Medical Imaging0 (SwePub)302082 hsv//eng
700a Lewin, Freddi,c Associate professoru Department of Oncology, County Hospital Ryhov, Jönköping, Sweden4 ths
700a Dabrosin, Charlotta,d 1961-u Linköpings universitet,Avdelningen för Kirurgi, Ortopedi och Onkologi,Medicinska fakulteten,Region Östergötland, Onkologiska kliniken US4 ths0 (Swepub:liu)chada67
700a Sharp, Lena,c Dr.u Regional Cancer Centre, Stockholm-Gotland, Stockholm, Sweden / Department of Learning, Informatics, Management and Ethics, Division of Innovative Care Research, Karolinska Institute,Stockholm, Sweden4 ths
700a Jensen, Lasse D,d 1979-u Linköpings universitet,Avdelningen för kardiovaskulär medicin,Medicinska fakulteten,Region Östergötland, Klinisk farmakologi4 ths0 (Swepub:liu)larje86
700a Brun, Eva,c Associate Professoru Department of Oncology and Pathology, Lund University, Lund, Sweden4 opn
710a Linköpings universitetb Avdelningen för Kirurgi, Ortopedi och Onkologi4 org
856u https://doi.org/10.3384/diss.diva-162101y Fulltext
856u https://liu.diva-portal.org/smash/get/diva2:1371186/FULLTEXT01.pdfx primaryx Raw objecty fulltext
856u https://liu.diva-portal.org/smash/get/diva2:1371186/PREVIEW01.pngx Previewy preview image
856u http://liu.diva-portal.org/smash/get/diva2:1371186/FULLTEXT01
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-162101
8564 8u https://doi.org/10.3384/diss.diva-162101

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy